US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.660
  • -0.080-1.19%
Close Apr 18 16:00 ET
556.90MMarket Cap-2134P/E (TTM)

About Verve Therapeutics Company

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Company Profile

SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sekar Kathiresan, M.D.
  • Chief Executive Officer and Director
  • 7.85M
  • Dr. Andrew Bellinger, M.D.
  • Chief Scientific Officer
  • 3.32M
  • Andrew D. Ashe
  • President and Chief Operating Officer
  • 3.32M
  • Allison Dorval
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Joan Nickerson
  • Chief Administrative Officer
  • --
  • Dr. Burt A. Adelman, M.D.
  • Chairman of the Board
  • 236.45K
  • Dr. Krishna Yeshwant
  • Independent Director
  • 192.91K
  • Sheila Mikhail
  • Independent Director
  • 195.41K
  • Lonnel Coats
  • Independent Director
  • 594.30K
  • Michael F. Maclean
  • Independent Director
  • 198.91K
  • Alexander G. Cumbo
  • Independent Director
  • 320.23K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg